These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 21479885)
1. Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation. Xavier CP; Lima CF; Rohde M; Pereira-Wilson C Cancer Chemother Pharmacol; 2011 Dec; 68(6):1449-57. PubMed ID: 21479885 [TBL] [Abstract][Full Text] [Related]
2. Apoptosis, cell cycle progression and gene expression in TP53-depleted HCT116 colon cancer cells in response to short-term 5-fluorouracil treatment. Adamsen BL; Kravik KL; Clausen OP; De Angelis PM Int J Oncol; 2007 Dec; 31(6):1491-500. PubMed ID: 17982676 [TBL] [Abstract][Full Text] [Related]
3. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy. Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829 [TBL] [Abstract][Full Text] [Related]
4. DNA damage signaling in response to 5-fluorouracil in three colorectal cancer cell lines with different mismatch repair and TP53 status. Adamsen BL; Kravik KL; De Angelis PM Int J Oncol; 2011 Sep; 39(3):673-82. PubMed ID: 21674128 [TBL] [Abstract][Full Text] [Related]
5. Docosahexaenoic acid enhances the susceptibility of human colorectal cancer cells to 5-fluorouracil. Calviello G; Di Nicuolo F; Serini S; Piccioni E; Boninsegna A; Maggiano N; Ranelletti FO; Palozza P Cancer Chemother Pharmacol; 2005 Jan; 55(1):12-20. PubMed ID: 15365767 [TBL] [Abstract][Full Text] [Related]
6. Influence of p53 status on radiation and 5-flourouracil synergy in pancreatic cancer cells. Mohiuddin M; Chendil D; Dey S; Alcock RA; Regine W; Mohiuddin M; Ahmed MM Anticancer Res; 2002; 22(2A):825-30. PubMed ID: 12014658 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of Fas expression by RNAi modulates 5-fluorouracil-induced apoptosis in HCT116 cells expressing wild-type p53. Borralho PM; Moreira da Silva IB; Aranha MM; Albuquerque C; Nobre Leitão C; Steer CJ; Rodrigues CM Biochim Biophys Acta; 2007 Jan; 1772(1):40-7. PubMed ID: 17056233 [TBL] [Abstract][Full Text] [Related]
8. The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis: time- and p53 expression-dependency of anti-cancer drugs. Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S Oncol Rep; 2005 Sep; 14(3):609-15. PubMed ID: 16077963 [TBL] [Abstract][Full Text] [Related]
9. Andrographolide enhances 5-fluorouracil-induced apoptosis via caspase-8-dependent mitochondrial pathway involving p53 participation in hepatocellular carcinoma (SMMC-7721) cells. Yang L; Wu D; Luo K; Wu S; Wu P Cancer Lett; 2009 Apr; 276(2):180-8. PubMed ID: 19097688 [TBL] [Abstract][Full Text] [Related]
10. Chronic exposure of colorectal cancer cells in culture to fluoropyrimidine analogs induces thymidylate synthase and suppresses p53. A molecular explanation for the mechanism of 5-FU resistance. Subbarayan PR; Sarkar M; Nelson G; Benitez E; Singhal S; Ardalan B Anticancer Res; 2010 Apr; 30(4):1149-56. PubMed ID: 20530421 [TBL] [Abstract][Full Text] [Related]
11. STAT5a-targeting miRNA enhances chemosensitivity to cisplatin and 5-fluorouracil in human colorectal cancer cells. Hong X; Chen G; Wang M; Lou C; Mao Y; Li Z; Zhang Y Mol Med Rep; 2012 May; 5(5):1215-9. PubMed ID: 22367509 [TBL] [Abstract][Full Text] [Related]
12. Expression of p53 protein as a predictor of the response to 5-fluorouracil and cisplatin chemotherapy in human gastrointestinal cancer cell lines evaluated with apoptosis by use of thin layer collagen gel. Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S Int J Oncol; 2004 Apr; 24(4):807-13. PubMed ID: 15010816 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. Li J; Hou N; Faried A; Tsutsumi S; Takeuchi T; Kuwano H Ann Surg Oncol; 2009 Mar; 16(3):761-71. PubMed ID: 19116755 [TBL] [Abstract][Full Text] [Related]
14. The roles of thymidylate synthase and p53 in regulating Fas-mediated apoptosis in response to antimetabolites. Longley DB; Allen WL; McDermott U; Wilson TR; Latif T; Boyer J; Lynch M; Johnston PG Clin Cancer Res; 2004 May; 10(10):3562-71. PubMed ID: 15161716 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of the p38 MAPK pathway sensitises human colon cancer cells to 5-fluorouracil treatment. Yang SY; Miah A; Sales KM; Fuller B; Seifalian AM; Winslet M Int J Oncol; 2011 Jun; 38(6):1695-702. PubMed ID: 21424124 [TBL] [Abstract][Full Text] [Related]
16. p53 dependence and apoptosis in response to FP treatment with p53-transfected colon cancer cell lines by use of thin layer collagen gel. Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S Oncol Rep; 2004 Aug; 12(2):357-61. PubMed ID: 15254702 [TBL] [Abstract][Full Text] [Related]
17. Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks. Wang W; McLeod HL; Cassidy J; Collie-Duguid ES Cancer Chemother Pharmacol; 2007 May; 59(6):839-45. PubMed ID: 17119966 [TBL] [Abstract][Full Text] [Related]
18. [Potentiation of 5-fluorouracil efficacy. Molecular mechanisms playing a role in the cytotoxic action of 5-fluorouracil and 5-ethyl-2'-deoxyuridine (EUdR) combination]. Katona C; Timár F; Oláh J; Bocsi J; Budai B; Otvös L; Kralovánszky J Magy Onkol; 2004; 48(3):243-51. PubMed ID: 15520875 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of hRFI inhibits 5-fluorouracil-induced apoptosis in colorectal cancer cells via activation of NF-kappaB and upregulation of BCL-2 and BCL-XL. Konishi T; Sasaki S; Watanabe T; Kitayama J; Nagawa H Oncogene; 2006 May; 25(22):3160-9. PubMed ID: 16407826 [TBL] [Abstract][Full Text] [Related]
20. 5-Fluorouracil efficiently enhanced apoptosis induced by adenovirus-mediated transfer of caspase-8 in DLD-1 colon cancer cells. Uchida H; Shinoura N; Kitayama J; Watanabe T; Nagawa H; Hamada H J Gene Med; 2003 Apr; 5(4):287-99. PubMed ID: 12692863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]